Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 4, 2004, Pages 646-649

  Raad, Issam ^a   Hachem, Ray ^a   Hanna, Hend ^a   Afif, Claude ^a,b   Escalante, Carmen ^a   Kantarjian, Hagop ^a   Rolston, Kenneth ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF BALAMAND   (Lebanon)

Author keywords

Enterococcal bacteraemia; Enterococcal infections; Resistant Gram positive infections; Synercid; Zyvox

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; LINEZOLID; VANCOMYCIN;

ADULT; AGED; ARTHRALGIA; ARTICLE; BACTERIAL INFECTION; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; ENTEROCOCCUS FAECIUM; FEMALE; FOLLOW UP; HUMAN; HYPERBILIRUBINEMIA; LEUKOPENIA; MALE; MYALGIA; NAUSEA AND VOMITING; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ACETAMIDES; ADULT; AGED; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OXAZOLIDINONES; PILOT PROJECTS; PROSPECTIVE STUDIES; VANCOMYCIN RESISTANCE; VIRGINIAMYCIN;

EID: 4544302794     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh144     Document Type: Article

References (12)

1. Edmond, M. B., Ober, J. F., Dawson, J. D. et al. (1996) Vancomycin-resistant enterococcal bacteraemia: natural history and attributable mortality. Clinical Infectious Diseases 23, 1234-9.
2. Montecalvo, M. A., Shay, D. K., Patel, P. et al. (1996). Blood-stream infections with vancomycin-resistant enterococci. Archives of Internal Medicine 156, 1458-62.
3. Eliopoulos, G. M. (2003). Quinupristin/dalfopristin and linezolid: evidence and opinion. Clinical Infectious Diseases 36, 473-81.
4. Linden, P. K., Moellering, R. C., Wood, C. A. et al. for the Synercid Emergency-Use Study Group. (2001). Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin. Clinical Infectious Diseases 33, 1816-23.
5. Birmingham, M. C., Rayner, C. R., Meagher A. K. et al. (2003). Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clinical Infectious Diseases 36, 159-68.
6. Raad, I., Hachem, R., Hanna, H. et al. (2001). Treatment of vancomycin-resistant enterococcal infections in the immunocompromised host: quinupristin-dalfopristin in combination with minocycline. Antimicrobial Agents and Chemotherapy 45, 3202-4.
7. Linden, P. K. (2002). Treatment options for vancomycin-resistant enterococcal infections. Drugs 62, 437-41.
8. Winston, D. J., Emmanouilides, C., Kroeber, A. et al. (2000). Quinupristin/dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium. Clinical Infectious Diseases 30, 790-7.
9. Olsen, K. M., Rebuck, J. A. & Rupp, M. E. (2001). Arthralgias and myalgias related to quinupristin-dalfopristin administration. Clinical Infectious Diseases 32, e83-6.
10. Carver, P. L., Whang, E., VandenBussche, H. L. et al. (2003). Risk factors for arthralgias or myalgias associated with quinupristin-dalfopristin therapy. Pharmacotherapy 23, 159-64.
11. Gerson, S. L., Kaplan, S. L., Bruss, J. B. et al. (2002). Haematological effects of linezolid: summary of clinical experience. Antimicrobial Agents and Chemotherapy 46, 2723-6.
12. Hachem, R. Y., Hicks, K., Huen, A. et al. (2003). Myelosuppression and serotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients. Clinical Infectious Diseases 37, e8-11.